Cooles FAH - Search Results

1

The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy.

Cooles FAH, Anderson AE, Lendrem DW, Norris J, Pratt AG, Hilkens CMU, Isaacs JD. Cooles FAH, et al. J Allergy Clin Immunol. 2018 Jan;141(1):445-448.e4. doi: 10.1016/j.jaci.2017.08.026. Epub 2017 Oct 5. J Allergy Clin Immunol. 2018. PMID: 28987811 Free PMC article. No abstract available.

2

Treating to re-establish tolerance in inflammatory arthritis - lessons from other diseases.

Cooles FA, Isaacs JD. Cooles FA, et al. Best Pract Res Clin Rheumatol. 2010 Aug;24(4):497-511. doi: 10.1016/j.berh.2010.01.007. Best Pract Res Clin Rheumatol. 2010. PMID: 20732648 Review.

3

Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis.

Cooles FA, Jackson GH, Menon G, Isaacs JD. Cooles FA, et al. Rheumatology (Oxford). 2011 Apr;50(4):810-2. doi: 10.1093/rheumatology/keq429. Epub 2011 Jan 5. Rheumatology (Oxford). 2011. PMID: 21208978 No abstract available.

4

Pathophysiology of rheumatoid arthritis.

Cooles FA, Isaacs JD. Cooles FA, et al. Curr Opin Rheumatol. 2011 May;23(3):233-40. doi: 10.1097/BOR.0b013e32834518a3. Curr Opin Rheumatol. 2011. PMID: 21427580 Review.

5

Prevalence and diagnostic outcome relating to vitamin D deficiency in new patients presenting to an early arthritis clinic over 12 months.

Cooles FA, Pratt AG, Wilson G, Isaacs JD, Ng WF. Cooles FA, et al. Clin Rheumatol. 2011 Aug;30(8):1137-8. doi: 10.1007/s10067-011-1800-8. Epub 2011 Jun 24. Clin Rheumatol. 2011. PMID: 21698398 No abstract available.

6

Treg cells in rheumatoid arthritis: an update.

Cooles FA, Isaacs JD, Anderson AE. Cooles FA, et al. Curr Rheumatol Rep. 2013 Sep;15(9):352. doi: 10.1007/s11926-013-0352-0. Curr Rheumatol Rep. 2013. PMID: 23888361 Review.

7

Emerging immunotherapies for rheumatoid arthritis.

Reynolds G, Cooles FA, Isaacs JD, Hilkens CM. Reynolds G, et al. Hum Vaccin Immunother. 2014;10(4):822-37. doi: 10.4161/hv.27910. Epub 2014 Feb 17. Hum Vaccin Immunother. 2014. PMID: 24535556 Free PMC article. Review.

8

Retrospective analysis of the role of serum vitamin D in early rheumatic disease.

Cooles FA, Pratt AG, Lendrem DW, Ng WF, Aspray TJ, Isaacs JD. Cooles FA, et al. Rheumatology (Oxford). 2015 Feb;54(2):374-5. doi: 10.1093/rheumatology/keu420. Epub 2014 Nov 17. Rheumatology (Oxford). 2015. PMID: 25406355 No abstract available.

9

Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies.

Cooles FA, Anderson AE, Drayton T, Harry RA, Diboll J, Munro L, Thalayasingham N, Östör AJ, Isaacs JD. Cooles FA, et al. Arthritis Res Ther. 2016 Dec 20;18(1):302. doi: 10.1186/s13075-016-1188-6. Arthritis Res Ther. 2016. PMID: 27993172 Free PMC article.

10

Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.

Cooles FAH, Anderson AE, Skelton A, Pratt AG, Kurowska-Stolarska MS, McInnes I, Hilkens CMU, Isaacs JD. Cooles FAH, et al. Front Immunol. 2018 May 9;9:755. doi: 10.3389/fimmu.2018.00755. eCollection 2018. Front Immunol. 2018. PMID: 29867920 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters